Search

Your search keyword '"Zembala, M."' showing total 141 results

Search Constraints

Start Over You searched for: Author "Zembala, M." Remove constraint Author: "Zembala, M."
141 results on '"Zembala, M."'

Search Results

1. Probing of polyelectrolyte monolayers by zeta potential and wettability measurements

2. Characterization of polyelectrolyte multilayers on mica and oxidized titanium by streaming potential and wetting angle measurements

3. Polyelectrolyte adsorption layers studied by streaming potential and particle deposition

4. Monocyte-T-cell interactions in pokeweed mitogen-activated cultures.

5. Non-specific inhibitor made by T acceptor cells inhibits both the afferent and efferent stage of the contact sensitivity reaction.

6. T suppressor cells and suppressor factor which act at the efferent stage of the contact sensitivity skin reaction: their production by mice injected with water-soluble, chemically reactive derivatives of oxazolone and picryl chloride.

7. The purification of specific anti-picryl T suppressor factor which depresses the passive transfer of contact sensitivity: affinity chromatography on antigen and Concanavalin A sepharose and specific elution with hapten and α-methylmannoside.

8. Isolation of human monocytes by rosetting with antibody coated human erythrocytes and isopycnic gradient centrifugation.

9. Activation of human monocytes for nitroblue tetrazolium reduction and the suppression of lymphocyte response to mitogens.

10. The effect of cyclophosphamide and irradiation on cells which suppress contact sensitivity in the mouse.

11. MACROPHAGE AND LYMPHOCYTE CO-OPERATION IN TARGET CELL DESTRUCTION IN VITRO.

13. The Induction of Delayed Hypersensitivity by Macrophage-associated Antigen.

14. The Role of Macrphages in the Cytotoxic Killing of Tumour Cells in Vitro. I. PRIMARY IMMUNIZATION OF LYMPHOCYTES IN VITRO FOR TARGET CELL KILLING AND THE MECHANISM OF LYMPHOCYTE-MACRPHAGE COOPERATION.

15. THE MECHANISM OF IMMUNOLOGICAL UNRESPONSIVENESS TO PICRYL CHLORIDE AND THE POSSIBLE ROLE OF ANTIBODY MEDIATED DEPRESSION.

16. The Rapid Purification of Peritoneal Exudate Macrophages by Ficoll (Polysucrose) Density Gradient Centrifugation.

17. Inflammatory components in endarterectomy lesions: an immunohistological study

20. A Comparison of Catalytic Properties of Cs xH3− xPW12O40 Salts of Various Cesium Contents in Gas Phase and Liquid Phase Reactions.

21. Risk Stratification of Patients With Severe Heart Failure Awaiting Heart Transplantation—Prospective National Registry POLKARD HF

22. Production of Delayed Hypersensitivity by Antigen Associated with Peritoneal Exudate Cells and the Effect of Pretreatment with Freund's Complete Adjuvant.

23. Concentration of Anti-7-ketocholesterol Antibodies in Patient Sera After Heart Transplantation

24. Pentoxyfylline in and prevention and treatment of chronic lung disease.

25. Speckle-Tracking Echocardiography for Monitoring Acute Rejection in Transplanted Heart.

26. Left Ventricular Assist Device Implantation in Patients With Optimal and Borderline Echocardiographic Assessment of Right Ventricle Function.

27. Predictive Value of Models for End-Stage Liver Disease Score in Patients With Pulsatile Flow POLVAD MEV Left Ventricular Assist Device Support.

28. Role of Pro-Brain Natriuretic Peptide Serum Concentration in the Detection of Pulmonary Hypertension in Patients With End-Stage Lung Diseases Referred for Lung Transplantation.

29. Red Blood Cell Distribution Width in End-Stage Heart Failure Patients Is Independently Associated With All-Cause Mortality After Orthotopic Heart Transplantation.

30. Prognostic Value of Mean, Diastolic, and Systolic Pulmonary Artery Pressure in Patients With End-stage Lung Disease Referred for Lung Transplantation.

31. Statistical properties of surfaces covered by large spheres.

33. Thyroid Function at Left Ventricular Assist Device (LVAD) Implantation Predicts Prognosis During LVAD Support.

34. Right Ventricular Function in Patients With Left Ventricular Assist Device Support by Pulsatile Polvad MEV and Continuous-Flow Pumps Heartware and Heartmate II.

35. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.

36. Perioperative Risk Factors of Cardiac Allograft Vasculopathy in the Long-Term Follow-up.

37. Effects of Left Ventricular Assist Device Support on End-Organ Function in Patients With Heart Failure: Comparison of Pulsatile- and Continuous-Flow Support in a Single-Center Experience.

38. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant.

39. Comparison of Mechanical Circulatory Support by the Use of Pulsatile Left Ventricular Assist Devices Polvad MEV and Continuous Flow Heart Ware and Heart Mate II in a Single-Center Experience.

40. BRCA1 Reflects Myocardial Adverse Remodeling in Idiopathic Dilated Cardiomyopathy.

42. Heart Retransplantation from an Anti-HBcore Positive Donor.

43. Early Pump Thrombosis Detection Algorithm in Patients Implanted with Heartware Pump.

44. The Evaluation of Alterations in Myocardial Deformation during Therapy of Acute Cellular Rejection.

45. Right Ventricular Free Wall Strain RVFWS as a Predictor of Outcome in Heart Transplantation Patients with COVID19 Disease.

46. Challenges in Heart Transplantation in COVID 19 Pandemic New Biopsy Protocol a Single Center Experience.

47. CMV Prophylaxis in the Optimization of Heart Transplant Recipients - A Single Center Open-Label Observational Study.

Catalog

Books, media, physical & digital resources